ADAP

Adaptimmune Therapeutics
ADAP

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ADAP was delisted on the 27th of October, 2025.

Back to rankings

45 hedge funds and large institutions have $380M invested in Adaptimmune Therapeutics in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$113M
2
+$80.9M
3
+$32.3M
4
FCMI
Foresite Capital Management II
California
+$32.2M
5
Capital World Investors
Capital World Investors
California
+$20M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$113M
2
$80.9M
3
$32.3M
4
$32.2M
5
$20M
6
$17.7M
7
$16.6M
8
$8.78M
9
$6.42M
10
$6.42M
11
$5.5M
12
$4.77M
13
$4.58M
14
$4.57M
15
$3.37M
16
$3.24M
17
$2.38M
18
$2.2M
19
$2.16M
20
$1.83M
21
$1.59M
22
$1.41M
23
$1.1M
24
$944K
25
$733K
1
2